AlgiPharma Announces $4 Million Award from Cystic Fibrosis Foundation Therapeutics to Advance Clinical Development of OligoG.
About Philip Rye
This author has yet to write their bio.Meanwhile lets just say that we are proud Philip Rye contributed a whooping 14 entries.
Entries by Philip Rye
AlgiPharma now features on the Cystic Fibrosis Foundation (CFF) drug development pipeline
AlgiPharma secures new license agreement with NTNU for exclusive global rights.
AlgiPharma granted Orphan Drug designation by FDA